Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Low-grade concern — timing, disclosure, or lab context
Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.
Mechanism and evidence
Both act on 5-alpha reductase, finasteride potently and saw palmetto weakly. In the two-year head-to-head trial finasteride grew hair in 68 percent of men against 38 percent for saw palmetto, so the herb adds no documented benefit on top and muddies attribution if side effects appear.
Evidence tier: rct
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- No trial tests saw palmetto added on top of finasteride; stacking a weak inhibitor onto a strong one has no documented upside.
- If you are considering replacing finasteride with saw palmetto, that is a prescriber conversation about efficacy, not a supplement swap.